On March 5, 2019 Array BioPharma Inc. (Nasdaq: ARRY) reported that its Chief Executive Officer, Ron Squarer, will speak at the 39th Annual Cowen Health Care Conference in Boston (Press release, Array BioPharma, MAR 5, 2019, View Source [SID1234534005]). The public is welcome to participate in the conference through a webcast on the Array BioPharma website.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event:

39th Annual Cowen Health Care Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Tuesday, March 12, 2019

Time:

12:00 p.m. Eastern Time

Webcast:

http://wsw.com/webcast/cowen52/arry/

A replay of the presentation will also be accessible under the "Investors/Investor Calendar" section of the website at www.arraybiopharma.com.

On March 5, 2019 Biogen Inc. (Nasdaq:BIIB) reported that it will present at the Cowen 39th Annual Health Care Conference (Press release, Biogen, MAR 5, 2019, http://investors.biogen.com/news-releases/news-release-details/biogen-present-cowen-39th-annual-health-care-conference [SID1234534021]). The webcast will be live on Monday, March 11, at 11:20 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at View Source An archived version of the webcast will be available following the presentation.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

On March 5, 2019 Bristol-Myers Squibb Company (NYSE:BMY) reported that it will take part in a fireside chat at the Cowen and Company 39th Annual Health Care Conference on Tuesday, March 12, 2019, in Boston (Press release, Bristol-Myers Squibb, MAR 5, 2019, https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-take-part-cowen-and-company-39th-annual-h [SID1234533949]). Giovanni Caforio, M.D., chairman and chief executive officer will answer questions at 11:20 a.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Investors and the general public are invited to listen to a live webcast of the session at View Source Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the session will be available later that day.

On March 5, 2019 Propanc Biopharma, Inc. (OTCQB:PPCB) ("Propanc"), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, reported that its Chief Executive Officer, James Nathanielsz, has been invited to present at the 31st Annual ROTH Conference being held on March 17 – 19, 2019 at the Ritz Carlton, Laguna Niguel located in Orange County, California (Press release, Propanc, MAR 5, 2019, View Source [SID1234533966]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The conference will feature presentations from public and private companies across a variety of industry sectors and is one of the largest of its kind in the US. Last year, the ROTH Conference hosted close to 550 participating companies and more than 4,700 attendees, including institutional investors, analysts, family offices and high net worth investors.

Mr. Nathanielsz is scheduled to present in one-on-one meetings with institutional analysts and investors throughout the day on March 19. He will be discussing Propanc’s plans for advancing its lead product, PRP, towards human trials this year.

ROTH will host a pre-recorded webcast of Propanc’s presentation, which will be available on the conference website at View Source beginning on March 11.

Investors and potential partners attending the conference who wish to meet with Propanc’s management can contact their ROTH representative. For those not planning to attend the conference, please contact Lisa DeScenza to set up a call with Mr. Nathanielsz to learn more about Propanc.

On March 5, 2019 LabCorp (NYSE: LH) reported it will participate at the 2019 Barclays Global Healthcare Conference (Press release, LabCorp, MAR 5, 2019, View Source [SID1234533983]. LabCorp’s presentation is planned for Tuesday, March 12, 2019, at 8:30 a.m. (ET).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast of the presentation will be available via the Company website at www.LabCorp.com and archived for replay.